Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Simulating Viral Dynamics in the New Trial Simulator

Antiviral drug development presents a unique set of challenges. First, viruses are constantly mutating, and drug-resistant viruses emerge easily. Therefore, combination therapies are typically required to maintain a sustained virologic response. In addition, successful treatment requires high medication adherence, which is often a challenge for patients with chronic viral infections such as hepatitis or HIV. […]

Author(s): Suzanne Minton, Bill Poland
More Info

Simulating Viral Dynamics in the New Trial Simulator

Watch this webinar to learn how to use simulation to anticipate risks and preview the range of possible trial results before millions of R&D dollars are spent exposing subjects to experimental therapies.

Speaker(s): Bill Poland
Solution: Clinical Trials Simulation, PK/PD Modeling & Simulation
Therapeutic Area: Infectious Disease
More Info